Effects of vitamin D supplementation on circulatory YKL-40 and MCP-1 biomarkers associated with vascular diabetic complications: A randomized, placebo-controlled, double-blind clinical trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Reddy, 2015, Epigenetic mechanisms in diabetic complications and metabolic memory, Diabetologia, 58, 443, 10.1007/s00125-014-3462-y
Forbes, 2013, Mechanisms of diabetic complications, Physiol Rev, 93, 137, 10.1152/physrev.00045.2011
Wolf, 2004, New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology, Eur J Clin Investig, 34, 785, 10.1111/j.1365-2362.2004.01429.x
Martini, 2008, Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge, Rev Endocr Metab Disord, 9, 267, 10.1007/s11154-008-9103-3
Johansen, 2006, Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer, Dan Med Bull, 53, 172
Rathcke, 2009, YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria, Diabetes Care, 32, 323, 10.2337/dc08-1144
Batinic, 2012, YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes, Atherosclerosis, 222, 557, 10.1016/j.atherosclerosis.2012.03.034
Di Rosa, 2016, Chitinase 3 like-1: an emerging molecule involved in diabetes and diabetic complications, Pathobiology, 83, 228, 10.1159/000444855
Kucur, 2007, Serum YKL-40 levels in patients with coronary artery disease, Coron Artery Dis, 18, 391, 10.1097/MCA.0b013e328241d991
Lee, 2012, Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients, J Diabetes Complicat, 26, 308, 10.1016/j.jdiacomp.2012.04.012
Lebensztejn, 2007, Serum level of YKL-40 does not predict advanced liver fibrosis in children with chronic hepatitis B, Adv Med Sci, 52, 120
Cekić, 2014, C-reactive protein and chitinase 3-like protein 1 as biomarkers of spatial redistribution of retinal blood vessels on digital retinal photography in patients with diabetic retinopathy, Bosn J Basic Med Sci, 14, 177, 10.17305/bjbms.2014.3.21
Agardh, 2015, Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy, BMC Med, 13, 182, 10.1186/s12916-015-0421-5
Tashiro, 2002, Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy, J Clin Lab Anal, 16, 1, 10.1002/jcla.2057
Sung, 2012, Role of vitamin D in insulin resistance, BioMed Res Int, 2012
Zhang, 2009, Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist, Am J Physiol Renal Physiol, 297, F791, 10.1152/ajprenal.00247.2009
Plum, 2012, Vitamin D compounds and diabetic nephropathy, Arch Biochem Biophys, 523, 87, 10.1016/j.abb.2012.02.008
Teng, 2005, Activated injectable vitamin D and hemodialysis survival: a historical cohort study, J Am Soc Nephrol, 16, 1115, 10.1681/ASN.2004070573
Trang, 1998, Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2, American. J. Clin. Nutrition., 68, 854, 10.1093/ajcn/68.4.854
Vasheghani-Farahani, 2011, The Persian, last 7-day, long form of the International Physical Activity Questionnaire: translation and validation study, Asian J Sports Med, 2, 106, 10.5812/asjsm.34781
McPhee, 2015, Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation, Clin Sci, 129, 1083, 10.1042/CS20150431
Williams, 2007, Inflammatory mechanisms of diabetic complications, Curr Diabetes Rep, 7, 242, 10.1007/s11892-007-0038-y
Kawada, 2007, Role of mammalian chitinases in inflammatory conditions, Keio J Med, 56, 21, 10.2302/kjm.56.21
Rehli, 2003, Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation, J Biol Chem, 278, 44058, 10.1074/jbc.M306792200
Libreros, 2012, Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model, Int J Cancer, 131, 377, 10.1002/ijc.26379
Choi, 2011, Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer's disease, J Neurol, 258, 2181
Kim, 2012, Involvement of the MAPK and PI3K pathways in chitinase 3-like 1-regulated hyperoxia-induced airway epithelial cell death, Biochem Biophys Res Commun, 421, 790, 10.1016/j.bbrc.2012.04.085
Bilim, 2010, Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure, J Card Fail, 16, 873, 10.1016/j.cardfail.2010.05.029
Sakamoto, 2013, Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus, Endocr J, 60, 73, 10.1507/endocrj.EJ12-0238
Xu, 2003, Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products, FASEB J, 17, 1289, 10.1096/fj.02-0490fje
de Lemos, 2003, Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes, Circulation, 107, 690, 10.1161/01.CIR.0000049742.68848.99
Rathcke, 2010, Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population, Int J Cardiol, 143, 35, 10.1016/j.ijcard.2009.01.043
Hua, 2004, The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha, Biochem J, 380, 651, 10.1042/bj20040099
Mous, 2018, Vitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials, Nutr Rev, 76, 380, 10.1093/nutrit/nux077
Zhang, 2007, 1, 25-Dihydroxyvitamin D3 targeting of NF-κB suppresses high glucose-induced MCP-1 expression in mesangial cells, Kidney Int, 72, 193, 10.1038/sj.ki.5002296
Gao, 2013, 1, 25-Dihydroxyvitamin D 3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes, Int J Obes, 37, 357, 10.1038/ijo.2012.53